One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Clinicopathologic Conference: A Four-Year-Old Child With Digital Clubbing
Katherine Schultz,Allison Divanovic,Christopher Towe,Alexander Miethke,Katie Wusik,Adrienne Hammill,Hermine Brunner
doi : 10.1002/acr.24428
Volume 73, Issue 10 p. 1379-1386
Using Critical Race Theory to Understand Trial Participation Among Black Individuals With Systemic Lupus Erythematosus: A Qualitative Study of Patients and Caregivers
Rodlescia S. Sneed,Maryann Mason,Jessica N. Williams,Corine Sinnette,Kreager Taber,Karen Mancera-Cuevas,Gina Curry,Patricia Canessa,Rosalind Ramsey-Goldman,Candace H. Feldman
doi : 10.1002/acr.24635
Volume 73, Issue 10 p. 1387-1395
Black patients with systemic lupus erythematous (SLE) experience greater disease incidence and severity than White patients, and yet they are underrepresented in SLE clinical trials. We applied Critical Race Theory to qualitatively explore the influence of racism on the underrepresentation of Black patients in SLE clinical trials and to develop a framework for future intervention.
Racial Differences in Contraception Encounters and Dispensing Among Female Medicaid Beneficiaries With Systemic Lupus Erythematosus
Jessica N. Williams,Chang Xu,Karen H. Costenbader,Bonnie L. Bermas,Lydia E. Pace,Candace H. Feldman
doi : 10.1002/acr.24346
Volume 73, Issue 10 p. 1396-1404
African American and Hispanic women with systemic lupus erythematosus (SLE) have the highest rates of potentially avoidable pregnancy complications, yet racial disparities in family planning among reproductive-age women with SLE have not been well-studied. Our objective was to examine whether there are racial differences in contraception encounters and dispensing among US Medicaid-insured women with SLE.
Obesity and the Risk of Incident Chronic Opioid Use in Rheumatoid Arthritis
Joshua F. Baker,Andrew Stokes,Sofia Pedro,Ted R. Mikuls,Michael George,Bryant R. England,Harlan Sayles,Fred Wolfe,Kaleb Michaud
doi : 10.1002/acr.24341
Volume 73, Issue 10 p. 1405-1412
The present study was undertaken to evaluate whether the rate of incident chronic opioid use is higher in obese patients with rheumatoid arthritis (RA).
Is There Any Role for Opioids in the Management of Knee and Hip Osteoarthritis? A Systematic Review and Meta-Analysis
Mikala C. Osani,L. Stefan Lohmander,Raveendhara R. Bannuru
doi : 10.1002/acr.24363
Volume 73, Issue 10 p. 1413-1424
Opioids have long been prescribed for chronic pain conditions, including osteoarthritis (OA). However, there is little information about their temporal efficacy, or differences in efficacy and safety between opioids with strong versus weak/intermediate ? opioid receptor–binding affinity. To explore these research questions, we conducted a systematic review and meta-analyses of randomized controlled trials (RCTs) conducted in patients with knee and/or hip OA.
Targeted Program in an Academic Rheumatology Practice to Improve Compliance With Opioid Prescribing Guidelines for the Treatment of Chronic Pain
Eric J. Wang,Rebecca Helgesen,Chadwick R. Johr,Hannah S. Lacko,Michael A. Ashburn,Peter A. Merkel
doi : 10.1002/acr.24354
Volume 73, Issue 10 p. 1425-1429
The Centers for Disease Control and Prevention (CDC) and many state governments have issued guidelines for opioid prescribing for the treatment of chronic noncancer-associated pain. We sought to decrease practice variation and increase compliance with these guidelines in a tertiary academic rheumatology practice by developing an interdisciplinary opioid working group and using electronic health record (EHR)–integrated data feedback.
Trends in Office Visits During Which Opioids Were Prescribed for Adults With Arthritis in the US, 2006–2015
Loredana Santo,Susan M. Schappert,Jennifer M. Hootman,Charles G. Helmick
doi : 10.1002/acr.24447
Volume 73, Issue 10 p. 1430-1435
To analyze trends for visits to office-based physicians at which opioids were prescribed among adults with arthritis in the US, from 2006 to 2015.
Cognitive Function Trajectories in Association With the Depressive Symptoms Trajectories in Systemic Lupus Erythematosus Over Time
Zahi Touma,Bahar Moghaddam,Jiandong Su,Patricia Katz
doi : 10.1002/acr.24349
Volume 73, Issue 10 p. 1436-1443
Cognitive function may change over time in patients with systemic lupus erythematosus (SLE), and cognitive function trajectories have not been well studied. We aimed to identify cognitive function trajectories in SLE and describe them with depressive symptoms trajectories, and we also aimed to identify baseline factors associated with class membership in the dual trajectories.
Mortality Among Hospitalized Individuals With Systemic Lupus Erythematosus in the US Between 2006 and 2016
Christine Anastasiou,Laura Trupin,David V. Glidden,Jing Li,Milena Gianfrancesco,Stephen Shiboski,Gabriela Schmajuk,Jinoos Yazdany
doi : 10.1002/acr.24356
Volume 73, Issue 10 p. 1444-1450
To evaluate time trends in mortality for hospitalized adults with systemic lupus erythematosus (SLE) compared to the general hospitalized population (GHP), and to identify factors associated with increased risk of death among hospitalized SLE patients.
Applying the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Lupus Criteria to Patients From the LUMINA Cohort: Results From the Multiethnic, Multicenter US Cohort
Manuel F. Ugarte-Gil,Guillermo J. Pons-Estel,Guillermina B. Harvey,Luis M. Vilá,Russell Griffin,Graciela S. Alarcón
doi : 10.1002/acr.24367
Volume 73, Issue 10 p. 1451-1455
To evaluate the performance of the 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) criteria for systemic lupus erythematosus (SLE) in terms of earlier SLE classification in comparison to the ACR or the Systemic Lupus International Collaborating Clinics (SLICC) criteria.
Defining Minimum Clinically Important Changes for the Patient Activity Scale II
Joshua F. Baker,Patti Katz,Kaleb Michaud
doi : 10.1002/acr.24335
Volume 73, Issue 10 p. 1456-1460
To define the minimum clinically important improvement (MCII) and minimum clinically important worsening (MCIW) for the Patient Activity Scale II (PAS-II; range 0–10), a recommended patient-reported outcome measuring rheumatoid arthritis disease activity.
Treatment Sequences After Discontinuing a Tumor Necrosis Factor Inhibitor in Patients With Rheumatoid Arthritis: A Comparison of Cycling Versus Swapping Strategies
Aliza R. Karpes Matusevich,Zhigang Duan,Hui Zhao,Lincy S. Lal,Wenyaw Chan,María E. Suarez-Almazor,Sharon H. Giordano,J. Michael Swint,Maria A. Lopez-Olivo
doi : 10.1002/acr.24358
Volume 73, Issue 10 p. 1461-1469
To evaluate the sequences of tumor necrosis factor inhibitors (TNFi) and non-TNFi used by rheumatoid arthritis (RA) patients whose initial TNFi therapy has failed, and to evaluate effectiveness and costs.
Randomized Controlled Trial of Patient Education Tools for Patients With Rheumatoid Arthritis
Maria A. Lopez-Olivo,Heather Lin,Tara Rizvi,Andrea Barbo Barthel,Aparna Ingleshwar,Jude K. A. des Bordes,Maria Jibaja-Weiss,Robert J. Volk,Maria E. Suarez-Almazor
doi : 10.1002/acr.24362
Volume 73, Issue 10 p. 1470-1478
The present study was undertaken to evaluate the efficacy of 2 educational tools for patients with rheumatoid arthritis (RA) by comparing a newly developed video tool, including storylines and testimonials, combined with a written booklet to the same written booklet alone.
Preferences for Self-Management and Support Services in Patients With Inflammatory Joint Disease: A Danish Nationwide Cross-Sectional Study
Nanna Maria Hammer,Caroline A. Flurey,Kim Vilbæk Jensen,Lena Andersen,Bente Appel Esbensen
doi : 10.1002/acr.24344
Volume 73, Issue 10 p. 1479-1489
To explore preferences for self-management and support services in patients with inflammatory joint disease (IJD) and to investigate whether these preferences differ by age, sex, diagnosis, and disease duration.
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
Medha Barbhaiya,Stephane Zuily,Yasaman Ahmadzadeh,Mary-Carmen Amigo,Tadej Avcin,Maria Laura Bertolaccini,D. Ware Branch,Guilherme de Jesus,Katrien M. J. Devreese,Camille Frances,David Garcia,Francis Guillemin,Steven R. Levine,Roger A. Levy,Michael D. Lockshin,Thomas L. Ortel,Surya V. Seshan,Maria Tektonidou,Denis Wahl,Rohan Willis,Ray Naden,Karen Costenbader,Doruk Erkan,on behalf of the New APS Classification Criteria Collaborators
doi : 10.1002/acr.24520
Volume 73, Issue 10 p. 1490-1501
An international multidisciplinary initiative, jointly supported by the American College of Rheumatology and European Alliance of Associations for Rheumatology, is underway to develop new rigorous classification criteria to identify patients with high likelihood of antiphospholipid syndrome (APS) for research purposes. The present study was undertaken to apply an evidence- and consensus-based approach to identify candidate criteria and develop a hierarchical organization of criteria within domains.
Trends in Systemic Sclerosis Mortality Over Forty-Eight Years, 1968–2015: A US Population–Based Study
Eric Y. Yen,Devanshu R. Singh,Ram R. Singh
doi : 10.1002/acr.24411
Volume 73, Issue 10 p. 1502-1510
To identify secular trends associated with systemic sclerosis (SSc) mortality over a 48-year period.
Lifetime Risk of Primary Shoulder Arthroplasty From 2008 to 2017: A Population-Level Analysis Using National Registry Data
Daisuke Miura,Ljoudmila Busija,Richard S. Page,Richard de Steiger,Michelle Lorimer,Ilana N. Ackerman
doi : 10.1002/acr.24353
Volume 73, Issue 10 p. 1511-1517
To estimate the lifetime risk of primary shoulder arthroplasty in Australia and to examine changes over time.
Machine Learning–Based Individualized Survival Prediction Model for Total Knee Replacement in Osteoarthritis: Data From the Osteoarthritis Initiative
Afshin Jamshidi,Jean-Pierre Pelletier,Aurelie Labbe,François Abram,Johanne Martel-Pelletier,Arnaud Droit
doi : 10.1002/acr.24601
Volume 73, Issue 10 p. 1518-1527
By using machine learning, our study aimed to build a model to predict risk and time to total knee replacement (TKR) of an osteoarthritic knee.
Participation in Informal Caregiving Among People With Arthritis: Findings From a Canadian Longitudinal Study on Aging
Jessica M. Wilfong,Anthony V. Perruccio,Dov B. Millstone,Elizabeth M. Badley
doi : 10.1002/acr.24329
Volume 73, Issue 10 p. 1528-1536
Despite the joint pain and significant dysfunction that characterizes arthritis, many people with arthritis continue to carry out everyday duties and responsibilities. The objective of the present study was to describe participation in informal caregiving (unpaid assistance to someone with a health issue or limitation) among people with arthritis.
Cost-Effectiveness of Colchicine Prophylaxis for Gout Flares When Commencing Allopurinol
Philip C. Robinson,Nicola Dalbeth,Peter Donovan
doi : 10.1002/acr.24357
Volume 73, Issue 10 p. 1537-1543
Colchicine prophylaxis to prevent gout flares when commencing urate-lowering therapy is recommended by international rheumatology society guidelines. Whether this is a cost-effective intervention is currently unknown. Our objective was to perform a cost-effectiveness analysis using both a US cost input model and an Australian cost input model.
Epidemiology, Time Trends, and Outcomes of Serious Infections in Patients With Vasculitis: A Nineteen-Year National Study
Jasvinder A. Singh,John D. Cleveland
doi : 10.1002/acr.24348
Volume 73, Issue 10 p. 1544-1551
To examine the epidemiology, time trends, and outcomes and types of serious infections in people with vasculitis in the US.
